Robert Lorne Hopfner has an estimated net worth of $189 Million. This is based on reported shares across multiple companies, which include Vaxcyte, Inc., Inozyme Pharma, Inc., Rallybio Corp, HYPERION THERAPEUTICS INC, and Evommune, Inc..

2023 was Robert Lorne Hopfner's most active year for acquiring shares with 9 total transactions. Robert Lorne Hopfner's most active month to acquire stocks was the month of May. 2021 was Robert Lorne Hopfner's most active year for disposing of shares, totalling 42 transactions. Robert Lorne Hopfner's most active month to dispose stocks was the month of December. 2021 saw Robert Lorne Hopfner paying a total of $7,499,999.00 for 2,294,118 shares, this is the most they've acquired in one year. In 2025 Robert Lorne Hopfner cashed out on 32,187,347 shares for a total of $17,979,404.00, their largest year based on trade value.